4 ms·
Biogen's stock performance yesterday was disturbing given the efficacy questions... This market feels whack. Anyone interested in a potentially more effective A
by bionhoward 5y ago
Biogen's stock performance yesterday was disturbing given the efficacy questions... This market feels whack. Anyone interested in a potentially more effective Alzheimer's AND Parkinson's drug might be interested in Annovis Bio: https://www.biospace.com/article/annovis-bio-shows-alzheimer-s-reversal-in-humans-in-phase-ii-study/ https://www.biospace.com/article/annovis-bio-shows-alzheimer...
Given better results, it's a sign the plaque theory is wrong...
- jcranmer 5y agoOh, Biogen's now guaranteed to make loads of money before the efficacy question comes back to bite them, because the FDA's approval greenlights them to sell it before the efficacy can be firmly resolved (i.e., they come out with their subsequent trial data which, if history is any indication, is pretty likely to say it doesn't work).